China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Short Interest Down 54.8% in March

Posted by Teresa Graham on Mar 30th, 2025

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC – Get Free Report) was the recipient of a significant decrease in short interest in the month of March. As of March 15th, there was short interest totalling 32,900 shares, a decrease of 54.8% from the February 28th total of 72,800 shares. Based on an average daily trading volume, of 127,900 shares, the days-to-cover ratio is presently 0.3 days. Currently, 0.2% of the company’s shares are short sold.

China SXT Pharmaceuticals Stock Up 2.2 %

NASDAQ:SXTC traded up $0.06 during mid-day trading on Friday, reaching $2.78. The company’s stock had a trading volume of 14,711 shares, compared to its average volume of 123,601. The company’s fifty day simple moving average is $3.42 and its two-hundred day simple moving average is $3.85. China SXT Pharmaceuticals has a twelve month low of $2.40 and a twelve month high of $26.96.

China SXT Pharmaceuticals Company Profile

(Get Free Report)

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.